Cargando…

THE RÔLE OF THE SOLUBLE SPECIFIC SUBSTANCE IN ORAL IMMUNIZATION AGAINST PNEUMOCOCCUS TYPE I

1. Feeding the purified soluble specific substance of Type I pneumococcus protects rats against an intraperitoneal injection of the virulent organism. 2. This increased resistance resembles that obtained when the intact (dead) or dissolved bacteria are fed, as follows: (a) one feeding is sufficient,...

Descripción completa

Detalles Bibliográficos
Autor principal: Ross, Victor
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 1931
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2180305/
https://www.ncbi.nlm.nih.gov/pubmed/19869967
_version_ 1782145520485007360
author Ross, Victor
author_facet Ross, Victor
author_sort Ross, Victor
collection PubMed
description 1. Feeding the purified soluble specific substance of Type I pneumococcus protects rats against an intraperitoneal injection of the virulent organism. 2. This increased resistance resembles that obtained when the intact (dead) or dissolved bacteria are fed, as follows: (a) one feeding is sufficient, (b) the interval between the feeding and the appearance of the immunity is the same, (c) the duration is approximately the same, (d) when the immunity is exhausted it can be renewed by a new feeding, (e) the immunizing action is type-specific. 3. The differences between the effects of feeding the purified specific substance and the intact or dissolved organism to rats, appear to be quantitative rather than qualitative, the proportion of animals protected and the height of the immunity being generally, though not always, less in the case of the former. 4. In contrast to the immunizing action which the soluble specific substance possesses when administered to rats, feeding it to mice failed to protect them. Neither were mice definitely immunized by parenteral administration. 5. A sodium glycocholate solution of Pneumococcus Type I lost part of its immunizing activity on standing for 1 year. 6. The failure to immunize mice and the loss of activity of the bile salt solution of pneumococcus, on standing, are discussed in terms of (a) the possible presence of a second cell constituent which is active by mouth, and (b) a possible intramolecular change in the type-specific polysaccharide associated with a loss of immunizing action while retaining the precipitin reaction.
format Text
id pubmed-2180305
institution National Center for Biotechnology Information
language English
publishDate 1931
publisher The Rockefeller University Press
record_format MEDLINE/PubMed
spelling pubmed-21803052008-04-18 THE RÔLE OF THE SOLUBLE SPECIFIC SUBSTANCE IN ORAL IMMUNIZATION AGAINST PNEUMOCOCCUS TYPE I Ross, Victor J Exp Med Article 1. Feeding the purified soluble specific substance of Type I pneumococcus protects rats against an intraperitoneal injection of the virulent organism. 2. This increased resistance resembles that obtained when the intact (dead) or dissolved bacteria are fed, as follows: (a) one feeding is sufficient, (b) the interval between the feeding and the appearance of the immunity is the same, (c) the duration is approximately the same, (d) when the immunity is exhausted it can be renewed by a new feeding, (e) the immunizing action is type-specific. 3. The differences between the effects of feeding the purified specific substance and the intact or dissolved organism to rats, appear to be quantitative rather than qualitative, the proportion of animals protected and the height of the immunity being generally, though not always, less in the case of the former. 4. In contrast to the immunizing action which the soluble specific substance possesses when administered to rats, feeding it to mice failed to protect them. Neither were mice definitely immunized by parenteral administration. 5. A sodium glycocholate solution of Pneumococcus Type I lost part of its immunizing activity on standing for 1 year. 6. The failure to immunize mice and the loss of activity of the bile salt solution of pneumococcus, on standing, are discussed in terms of (a) the possible presence of a second cell constituent which is active by mouth, and (b) a possible intramolecular change in the type-specific polysaccharide associated with a loss of immunizing action while retaining the precipitin reaction. The Rockefeller University Press 1931-11-30 /pmc/articles/PMC2180305/ /pubmed/19869967 Text en Copyright © Copyright, 1931, by The Rockefeller Institute for Medical Research New York This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/).
spellingShingle Article
Ross, Victor
THE RÔLE OF THE SOLUBLE SPECIFIC SUBSTANCE IN ORAL IMMUNIZATION AGAINST PNEUMOCOCCUS TYPE I
title THE RÔLE OF THE SOLUBLE SPECIFIC SUBSTANCE IN ORAL IMMUNIZATION AGAINST PNEUMOCOCCUS TYPE I
title_full THE RÔLE OF THE SOLUBLE SPECIFIC SUBSTANCE IN ORAL IMMUNIZATION AGAINST PNEUMOCOCCUS TYPE I
title_fullStr THE RÔLE OF THE SOLUBLE SPECIFIC SUBSTANCE IN ORAL IMMUNIZATION AGAINST PNEUMOCOCCUS TYPE I
title_full_unstemmed THE RÔLE OF THE SOLUBLE SPECIFIC SUBSTANCE IN ORAL IMMUNIZATION AGAINST PNEUMOCOCCUS TYPE I
title_short THE RÔLE OF THE SOLUBLE SPECIFIC SUBSTANCE IN ORAL IMMUNIZATION AGAINST PNEUMOCOCCUS TYPE I
title_sort rôle of the soluble specific substance in oral immunization against pneumococcus type i
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2180305/
https://www.ncbi.nlm.nih.gov/pubmed/19869967
work_keys_str_mv AT rossvictor theroleofthesolublespecificsubstanceinoralimmunizationagainstpneumococcustypei
AT rossvictor roleofthesolublespecificsubstanceinoralimmunizationagainstpneumococcustypei